XLON
RTW
Market cap777mUSD
Oct 30, Last price
2.42USD
1D
-1.22%
1Q
-2.02%
IPO
115.11%
Name
RTW Venture Fund Ltd
Chart & performance
P/E
22.74
P/B
3.62
EPS
0.11
Vol. 1Y
24.94%
Shs. 5Y
17.81%
Rev. 5Y
1.84%
Div Yld LY
—
Div Yld TTM
—
Revenues
8m
-90.51%
Net income
34m
-58.91%
CFO
-124m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
RTW Venture Fund Limited primarily focuses on sourcing groundbreaking innovations poised for substantial growth within the biotechnology, pharmaceutical, and medical technology fields. The fund allocates capital to enterprises that are engineering advanced therapies and cutting-edge technologies, ultimately aiming to profoundly enhance patient quality of life.
Key people
William Simpson
Independent Chairman of the Board · since 2019
Stephanie Sirota
Non-Executive Director, Chief Business Officer · since 2019
Senior Non-Executive Independent Director · since 2024
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2019
IPO date
Oct 30, 2019
Employees
Domiciled in
GG
Incorporated in
GG
Headquarters & legal address
PO BOX 650, 1ST FLOOR, ROYAL CHAMBERS, ST JULIAN'S AVENUE
SAINT PETER PORT GY1 3JX
GG
SAINT PETER PORT GY1 3JX
GG
Previous name
RTW VENTURE FUND LIMITED
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||